Natriuretic response prediction equation for use with oral diuretics in heart failure: read more in EHJ. @ESCardio @ESC_Journals #HeartFailure #Diuretics #EHJ #CardiologyResearch

First myocardial infarction: risk factors, symptoms, and medical therapy: read more in EHJ. @ESCardio @ESC_Journals #MyocardialInfarction #Cardiology #EHJ #CardiacCare

Pulmonary arterial wedge pressure (PAWP) sometimes exceeds left atrial pressure (LAP)—an apparent paradox with big implications in heart failure and pulmonary disease: read more in EHJ. @ESCardio @ESC_Journals #PAWP #LAP @bborlaugmd @MayoClinicCV

EHJ issue 46 - 25 is online:. Delve into heart failure: obesity paradox, implementation of GRMT, natriuretic response prediction score and new therapeutic targets. @escardio @ESC_Journals #EHJ #cardiotwitter

Redefining obesity: beyond body mass index: read more in EHJ. @ESCardio @ESC_Journals #obesity @JavedButler1 @Dr_Fioretti @profmjdavies

Medial arterial calcification in ageing and disease: current evidence and knowledge gaps: Discover the latest insights now! Read more in EHJ. @ESCardio @ESC_Journals #ageing

Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes. Read more in EHJ. @ESCardio @ESC_Journals

Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement just published in EHJ. @ESCardio @ESC_Journals #vaccines

RT @ESCardioNews: The new ESC Clinical Consensus Statement published in the #EHJ discusses the key role of #vaccination in preventing cardi….

RT @escardio: #EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it….

Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial in EHJ. @ESCardio @ESC_Journals #PV_thrombosis

Body ax indexI is simple, but oversimplified. To truly understand obesity, we need to measure body composition not just weight and height. Read more in #EHJ. #diabetes #metabolicdisorder #cardiotwitter @ESC_Journals @escardio

For patients with blocked artificial heart valves, surgery isn’t always the safer or better option. Fibrinolytic therapy can work just as well with fewer serious risks. Read more in #EHJ. #valve #thrombosis #cardiotwitter @ESC_Journals @escardio

Medial Arterial Calcification: not just ageing, but disease-accelerated. Shared pathways in diabetes & kidney disease reveal targets—and gaps—in our understanding. Time to crack the code. Read more in #EHJ. #cardiotwitter @ESC_Journals @escardio

Smooth muscle cells: the silent drivers of atherosclerosis. From clonal expansion to therapeutic targets, time to bring them to the forefront. Read more in #EHJ. #CardioResearch #TranslationalMedicine #cardiotwitter @ESC_Journals @escardio

Former elite rowers exhibit a 7-fold increased risk of atrial fibrillation compared to matched controls. Cardiac remodeling and genetic predisposition likely contribute. Read more in #EHJ. #atrialfibrillation #sport #cardiotwitter @ESC_Journals @escardi

Infective endocarditis is deadly and increasingly complex. Aging patients, drug use, prosthetics, and resistant pathogens demand a multidisciplinary team approach. Read more in #EHJ. #cardiotwitter @ESC_Journals @escardio

EHJ Dialogue with Profs. Thomas Lüscher, Tomasz Guzik, and Ulf Landmesser on the European Society of Cardiology (ESC)

Reminder to join our next EHJ Dialogue later today (Thursday, 17:00 CEST): Profs. @TomLuscher, @CVR_TomaszGuzik, and Ulf Landmesser will join our Editor in Chief to discuss all things #ESCCongress 2025. Register here to join the conversation:

Mixed valvular heart disease: moderate stenosis and regurgitation may represent severe disease. Echo is the first step, but multimodality imaging and assessment of global impact are key. Read more in #EHJ. #valve #cardiotwitter @ESC_Journals @escardio